Huadong Medicine Co., Ltd (SHE: 000963)
China
· Delayed Price · Currency is CNY
28.61
-0.11 (-0.38%)
Sep 9, 2024, 1:42 PM CST
Huadong Medicine Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 3,101 | 2,839 | 2,499 | 2,302 | 2,820 | 2,813 | Upgrade
|
Depreciation & Amortization | 884.26 | 795.45 | 705.55 | 591.56 | 431 | 404.48 | Upgrade
|
Other Amortization | 30.5 | 23.79 | 6.65 | 5.96 | 8.54 | 9.89 | Upgrade
|
Loss (Gain) From Sale of Assets | -5.73 | -4.32 | -8.26 | 0.03 | -322.64 | -114.15 | Upgrade
|
Asset Writedown & Restructuring Costs | 25.08 | 18.9 | -22.6 | 8.02 | 2.51 | 4.58 | Upgrade
|
Loss (Gain) From Sale of Investments | 86 | 188.39 | 115.62 | 52.91 | 7.93 | -11.06 | Upgrade
|
Provision & Write-off of Bad Debts | 47.27 | 25.76 | 68.69 | 41.69 | 22.83 | 28.58 | Upgrade
|
Other Operating Activities | 37.74 | 121.32 | 137.61 | 132.51 | 179.92 | 209.98 | Upgrade
|
Change in Accounts Receivable | -1,727 | -968.97 | -2,095 | -775.57 | -530.3 | -815.96 | Upgrade
|
Change in Inventory | -405.52 | 213.85 | -491.52 | 18.09 | -37.73 | -159.6 | Upgrade
|
Change in Accounts Payable | 2,116 | 685.55 | 1,450 | 770.58 | 797.16 | -368.87 | Upgrade
|
Change in Other Net Operating Assets | 53.5 | 43.01 | 7.24 | - | 4.9 | - | Upgrade
|
Operating Cash Flow | 4,183 | 3,929 | 2,382 | 3,170 | 3,411 | 2,002 | Upgrade
|
Operating Cash Flow Growth | 1.54% | 64.96% | -24.86% | -7.08% | 70.43% | -1.85% | Upgrade
|
Capital Expenditures | -1,667 | -1,607 | -1,193 | -819.1 | -1,473 | -1,353 | Upgrade
|
Sale of Property, Plant & Equipment | 12.46 | 10.85 | 15.43 | 79.16 | 373.81 | 57.93 | Upgrade
|
Cash Acquisitions | -205.91 | -165.94 | -415.09 | -819.6 | - | -39.96 | Upgrade
|
Divestitures | - | - | - | -113.37 | - | - | Upgrade
|
Investment in Securities | -211.5 | -115.24 | -948.91 | -357.5 | -629.8 | -256.94 | Upgrade
|
Other Investing Activities | 229.6 | 126.4 | 106.2 | 43.72 | -9.66 | 9.81 | Upgrade
|
Investing Cash Flow | -1,842 | -1,751 | -2,436 | -1,987 | -1,739 | -1,583 | Upgrade
|
Long-Term Debt Issued | - | 4,876 | 4,975 | 2,259 | 2,211 | 1,908 | Upgrade
|
Total Debt Issued | 5,305 | 4,876 | 4,975 | 2,259 | 2,211 | 1,908 | Upgrade
|
Long-Term Debt Repaid | - | -5,729 | -4,653 | -2,405 | -2,278 | -1,880 | Upgrade
|
Total Debt Repaid | -5,111 | -5,729 | -4,653 | -2,405 | -2,278 | -1,880 | Upgrade
|
Net Debt Issued (Repaid) | 194.71 | -852.43 | 322.13 | -146.03 | -67.22 | 27.98 | Upgrade
|
Issuance of Common Stock | 10.63 | 10.63 | 104.65 | - | - | - | Upgrade
|
Common Dividends Paid | -1,069 | -594.21 | -576.49 | -460.11 | -565.73 | -570.63 | Upgrade
|
Other Financing Activities | -88.26 | 42.66 | 50.01 | -161.31 | -92.78 | -65.95 | Upgrade
|
Financing Cash Flow | -954.1 | -1,393 | -99.71 | -767.45 | -725.73 | -608.6 | Upgrade
|
Foreign Exchange Rate Adjustments | -8.79 | 5.95 | -9.77 | 7.11 | -21.44 | 22.57 | Upgrade
|
Net Cash Flow | 1,377 | 791.25 | -163.23 | 422.73 | 925.64 | -166.94 | Upgrade
|
Free Cash Flow | 2,516 | 2,323 | 1,189 | 2,351 | 1,938 | 648.25 | Upgrade
|
Free Cash Flow Growth | -14.21% | 95.40% | -49.43% | 21.26% | 199.03% | -44.26% | Upgrade
|
Free Cash Flow Margin | 6.11% | 5.72% | 3.15% | 6.80% | 5.76% | 1.83% | Upgrade
|
Free Cash Flow Per Share | 1.44 | 1.33 | 0.68 | 1.34 | 1.11 | 0.37 | Upgrade
|
Cash Interest Paid | - | - | 0.62 | 0.95 | - | - | Upgrade
|
Cash Income Tax Paid | 2,639 | 2,552 | 3,018 | 1,539 | 2,165 | 2,115 | Upgrade
|
Levered Free Cash Flow | 2,252 | 1,905 | 604.48 | 2,104 | 1,160 | 210.77 | Upgrade
|
Unlevered Free Cash Flow | 2,324 | 1,977 | 679.51 | 2,147 | 1,203 | 277.76 | Upgrade
|
Change in Net Working Capital | -730.5 | -477.31 | 811.18 | -614.8 | -340.75 | 775.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.